Bibliography
- Perou CM , SorlieT, EisenMB et al.: Molecular portraits of human breast tumours.Nature406 , 747–752 (2000).
- Rouzier R , PerouCM, SymmansWF et al.: Breast cancer molecular subtypes respond differently to preoperative chemotherapy.Clin. Cancer. Res.11(16) , 5678–5685 (2005).
- Liedtke C , MazouniC, HessKR et al.: Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer.J. Clin. Oncol.26(8) , 1275–1281 (2008).
- Singletary SE , AllredC, AshleyP et al.: Revision of the American Joint Committee on cancer staging system for breast cancer.J. Clin. Oncol.20(17) , 3628–3636 (2002).
- Ross JS , HatzisC, SymmansWF et al.: Commercialized multigene predictors of clinical outcome for breast cancer.Oncologist13 , 477–493 (2008).
- Paik S , ShakS, TangG et al.: A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer.N. Engl. J. Med.351 , 2817–2826 (2004).
- Paik S , TangG, ShakS et al.: Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer.J. Clin. Oncol.24 , 3726–3734 (2006).
- Pusztai L , BroglioK, AndreF et al.: Effect of molecular disease subsets on disease-free survival in randomized adjuvant chemotherapy trials for estrogen-receptor positive breast cancer.J. Clin. Oncol.26(28) , 4679–4683 (2008).
- Pusztai L , HatzisC, CardosoF et al.: Combined use of genomic prognostic and treatment response predictors in lymph node-negative breast cancer.J. Clin. Oncol.26(15S) , S13 (2008).
▪ Websites
- Susan G: Komen Foundation Promise Grants http://cms.komen.org/komen/GrantsProgram/ResearchGrants/index.htm
- Adjuvant! Online www.adjuvantonline.com